Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Logue

Showing results (61-70 of 74) with videos related to

Pageof 8
Sort By:
International Journal of Clinical Pharmacology and Therapeutics|October 29, 2010
Pharmacokinetic and tolerability profile of once-daily zibotentan (ZD4054) in Japanese and Caucasian patients with hormone-resistant prostate cancerM Ranson, R H Wilson, J M O'Sullivan, et al.
European Journal of Cancer (Oxford, England : 1990)|December 22, 2009
Efficacy of data capture for patient-reported toxicity following radiotherapy for prostate or cervical cancerDamian J J Farnell, Jacqueline Routledge, Rita Hannon, et al.
Cancer Research|August 28, 2001
Carbonic anhydrase (CA IX) expression, a potential new intrinsic marker of hypoxia: correlations with tumor oxygen measurements and prognosis in locally advanced carcinoma of the cervixJ A Loncaster, A L Harris, S E Davidson, et al.
Magnetic Resonance in Medicine|July 29, 2010
Tracer kinetic analysis of dynamic contrast-enhanced MRI and CT bladder cancer data: A preliminary comparison to assess the magnitude of water exchange effectsLauren J Bains, Deirdre M McGrath, Josephine H Naish, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 22, 2010
Development of a patient-reported questionnaire for collecting toxicity data following prostate brachytherapyDamian J J Farnell, Paula Mandall, Carmel Anandadas, et al.
International Journal of Radiation Oncology, Biology, Physics|April 20, 2004
Radiotherapy for muscle-invasive carcinoma of the bladder: results of a randomized trial comparing conventional whole bladder with dose-escalated partial bladder radiotherapyRichard A Cowan, Catherine A McBain, W David J Ryder, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 18, 2000
Tumour oxygenation levels correlate with dynamic contrast-enhanced magnetic resonance imaging parameters in carcinoma of the cervixR A Cooper, B M Carrington, J A Loncaster, et al.
International Journal of Radiation Oncology, Biology, Physics|October 16, 2002
Prediction of radiotherapy outcome using dynamic contrast enhanced MRI of carcinoma of the cervixJuliette A Loncaster, Bernadette M Carrington, Johnathan R Sykes, et al.
Magnetic Resonance in Medicine|March 26, 2011
Comparison of dynamic contrast-enhanced MRI and dynamic contrast-enhanced CT biomarkers in bladder cancerJ H Naish, D M McGrath, L J Bains, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2011
Phase II study of conformal hypofractionated radiotherapy with concurrent gemcitabine in muscle-invasive bladder cancerAnanya Choudhury, Ric Swindell, John P Logue, et al.
Pageof 8

Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
International Journal of Clinical Pharmacology and Therapeutics|October 29, 2010
Pharmacokinetic and tolerability profile of once-daily zibotentan (ZD4054) in Japanese and Caucasian patients with hormone-resistant prostate cancerM Ranson, R H Wilson, J M O'Sullivan, et al.
European Journal of Cancer (Oxford, England : 1990)|December 22, 2009
Efficacy of data capture for patient-reported toxicity following radiotherapy for prostate or cervical cancerDamian J J Farnell, Jacqueline Routledge, Rita Hannon, et al.
Cancer Research|August 28, 2001
Carbonic anhydrase (CA IX) expression, a potential new intrinsic marker of hypoxia: correlations with tumor oxygen measurements and prognosis in locally advanced carcinoma of the cervixJ A Loncaster, A L Harris, S E Davidson, et al.
Magnetic Resonance in Medicine|July 29, 2010
Tracer kinetic analysis of dynamic contrast-enhanced MRI and CT bladder cancer data: A preliminary comparison to assess the magnitude of water exchange effectsLauren J Bains, Deirdre M McGrath, Josephine H Naish, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 22, 2010
Development of a patient-reported questionnaire for collecting toxicity data following prostate brachytherapyDamian J J Farnell, Paula Mandall, Carmel Anandadas, et al.
International Journal of Radiation Oncology, Biology, Physics|April 20, 2004
Radiotherapy for muscle-invasive carcinoma of the bladder: results of a randomized trial comparing conventional whole bladder with dose-escalated partial bladder radiotherapyRichard A Cowan, Catherine A McBain, W David J Ryder, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 18, 2000
Tumour oxygenation levels correlate with dynamic contrast-enhanced magnetic resonance imaging parameters in carcinoma of the cervixR A Cooper, B M Carrington, J A Loncaster, et al.
International Journal of Radiation Oncology, Biology, Physics|October 16, 2002
Prediction of radiotherapy outcome using dynamic contrast enhanced MRI of carcinoma of the cervixJuliette A Loncaster, Bernadette M Carrington, Johnathan R Sykes, et al.
Magnetic Resonance in Medicine|March 26, 2011
Comparison of dynamic contrast-enhanced MRI and dynamic contrast-enhanced CT biomarkers in bladder cancerJ H Naish, D M McGrath, L J Bains, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2011
Phase II study of conformal hypofractionated radiotherapy with concurrent gemcitabine in muscle-invasive bladder cancerAnanya Choudhury, Ric Swindell, John P Logue, et al.
Pageof 8